- |||||||||| Actemra IV (tocilizumab) / Roche, JW Pharma
[VIRTUAL] COVID-19 and Kidney Transplant Outcomes (On-Demand) - Oct 11, 2020 - Abstract #KIDNEYWEEK2020KIDNEY_WEEK_1395; Differing outcomes may be related to small number of cases, potentially varying acuities of illness and follow up periods. Given that cytokine storm occurs late in the course of COVID-19, it is plausible that mortality may increase in studies with short follow up.
- |||||||||| Vyrologix (leronlimab) / CytoDyn, Vyera Pharma
#leronlimab $cydy (Twitter) - Sep 21, 2020
|